JENNIFER ENTREKIN: Open Payments
NPI 1619369378 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $276 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $170 |
| PFIZER INC. | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| GENZYME CORPORATION | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: LifeVest, ELIQUIS, JARDIANCE, FABRAZYME, CAMZYOS, VYNDAQEL, FARXIGA, EVKEEZA.
Industry payments across DE — which companies pay providers there.
